CE-1037: Filed IND for a Phase I trial

Cortech Inc. (CRTQ), Denver Product: CE-1037, human neutrophil elastase inhibitor Indication: Adult Respiratory Distress Syndrome Status: Filed IND for a Phase I trial in healthy volunteers Note: CRT...